Veru Inc. (VERU:NASDAQ) shot up at $14.3, representing a gain of 42.9%. On Tue, Apr 12, 2022, VERU:NASDAQ hit a New 2-Week Intraday High of $13.86. The stock appeared on our News Catalysts scanner on Tue, Apr 12, 2022 at 06:06 PM in the 'MISCELLANEOUS' category. From Tue, Mar 29, 2022, the stock recorded 30.00% Up Days and 18.18% Green Days
The stock spiked on Mon, Apr 11, 2022 at $14.57 with a volume of 339M+.
About Veru Inc. (VERU:NASDAQ)
Veru Inc is a biopharmaceutical company focused on urology and oncology. It develops prescription products for benign prostatic hyperplasia hot flashes associated with cancer treatment, male infertility and novel chemotherapies for a variety of cancers.
Top 10 Gainers:
- Kaleido Biosciences, Inc. (KLDO:NASDAQ), 75.06%
- Antares Pharma, Inc. (ATRS:NASDAQ), 49.2%
- Veru Inc. (VERU:NASDAQ), 42.86%
- Sierra Oncology, Inc. (SRRA:NASDAQ), 38.54%
- Biofrontera Inc. (BFRI:NASDAQ), 34.05%
- Creatd Inc. (CRTD:NASDAQ), 33.14%
- HighPeak Energy Inc. (HPK:NASDAQ), 31.76%
- Planet Green Holdings Corp. (PLAG:NYSEMKT), 26.8%
- Turning Point Therapeutics, Inc. (TPTX:NASDAQ), 25.13%
- Hallador Energy Company (HNRG:NASDAQ), 25.06%